Tata Sierra 2025 launched at Rs 11.49 lakh: Bold SUV design, luxury interiors, advanced features; is it the perfect family SUV

The TATA Sierra has returned with a striking makeover, blending luxury, technology, and performance for the premium SUV market. Priced from Rs 11.49 Lakh, it aims to offer an aspirational yet attainable driving experience. With its “Escape Mediocre” ethos, the Sierra transforms every journey into an extraordinary adventure through comfort, advanced features, and robust performance.

Read More

Jharkhand Sets Up 43 Checkpoints Ahead of Bihar Assembly Elections to Ensure Security

Jharkhand has established 43 checkpoints on its Bihar border for the upcoming assembly elections. Additionally, 10 posts are requested along West Bengal and Odisha borders for the Ghatshila bypoll. Coordination meetings are underway across all administrative levels. The state also reported a decrease in pending criminal cases and significant action against cybercrime, with numerous arrests…

Read More

US market outlook: Wall Street braces for CPI test as rally nears record highs; analysts flag pullback risk; tariff impact in focus

Wall Street braces for a potential pullback as US inflation data looms, testing the market’s record-breaking rally. Strategists caution that valuations are stretched amid tariff risks and seasonally weak months. Stronger-than-expected inflation could dampen expectations for aggressive Fed rate cuts, while escalating trade tensions continue to cast a shadow over the economic outlook.

Read More

Nvidia CEO Jensen Huang has a shocking answer to Akshay Kumar’s biggest AI question: ‘What’s the one thing AI can’t copy from humans’

At the Nvidia AI Summit 2024 in Mumbai, Akshay Kumar questioned Jensen Huang about AI’s limitations, sparking a viral discussion on its role. Huang clarified that AI serves as a powerful augmentation tool, enhancing human capabilities but not replacing them entirely. He emphasized the importance of safety, ethical design, and collaboration to ensure responsible AI…

Read More

US pharma threats: Donald Trump says ‘very high tariff’ for drug companies by the end of month; semiconductors to follow soon

President Trump announced potential tariffs on imported pharmaceuticals by month’s end, followed by semiconductor levies. These actions, under Section 232, aim to bolster US production, citing national security concerns due to high import volumes. The pharmaceutical tariffs could significantly impact major drugmakers, while semiconductor tariffs may affect tech giants and consumer prices.

Read More